Abstract
Management of patients with channelopathies represents a challenging field for the electrophysiologist because, given the absence of obvious structural abnormalities of the cardiac tissue, it is difficult to define paradigms for the use of mapping and ablation. Anecdotal reports and studies conducted in limited numbers of patients support the view that ablative procedures should be part of the clinical armamentarium used to treat ion channel disorders, yet conclusive data are far from being available. We believe that the nuanced nature of heritable arrhythmogenic disease presents distinct challenges to mapping and radiofrequency ablation; therefore, in the present chapter we review currently available studies as well as selected cases from our experience focusing on patients with long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. This edition first published 2013
| Original language | English |
|---|---|
| Title of host publication | Cardiac Mapping: Fourth Edition |
| Publisher | Wiley-Blackwell |
| Pages | 644-655 |
| Number of pages | 12 |
| ISBN (Print) | 9780470670460 |
| DOIs | |
| Publication status | Published - Dec 18 2012 |
Fingerprint
Keywords
- Ablation
- Catecholaminergic
- Disease
- Genetic
- Inherited
- Long QT
- Mapping
- Ventricular arrhythmias
ASJC Scopus subject areas
- Medicine(all)
Cite this
Role of Mapping and Ablation in Genetic Diseases : Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia. / Fowler, Steven J.; Chinitz, Larry A.; Priori, Silvia G.
Cardiac Mapping: Fourth Edition. Wiley-Blackwell, 2012. p. 644-655.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Role of Mapping and Ablation in Genetic Diseases
T2 - Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia
AU - Fowler, Steven J.
AU - Chinitz, Larry A.
AU - Priori, Silvia G.
PY - 2012/12/18
Y1 - 2012/12/18
N2 - Management of patients with channelopathies represents a challenging field for the electrophysiologist because, given the absence of obvious structural abnormalities of the cardiac tissue, it is difficult to define paradigms for the use of mapping and ablation. Anecdotal reports and studies conducted in limited numbers of patients support the view that ablative procedures should be part of the clinical armamentarium used to treat ion channel disorders, yet conclusive data are far from being available. We believe that the nuanced nature of heritable arrhythmogenic disease presents distinct challenges to mapping and radiofrequency ablation; therefore, in the present chapter we review currently available studies as well as selected cases from our experience focusing on patients with long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. This edition first published 2013
AB - Management of patients with channelopathies represents a challenging field for the electrophysiologist because, given the absence of obvious structural abnormalities of the cardiac tissue, it is difficult to define paradigms for the use of mapping and ablation. Anecdotal reports and studies conducted in limited numbers of patients support the view that ablative procedures should be part of the clinical armamentarium used to treat ion channel disorders, yet conclusive data are far from being available. We believe that the nuanced nature of heritable arrhythmogenic disease presents distinct challenges to mapping and radiofrequency ablation; therefore, in the present chapter we review currently available studies as well as selected cases from our experience focusing on patients with long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. This edition first published 2013
KW - Ablation
KW - Catecholaminergic
KW - Disease
KW - Genetic
KW - Inherited
KW - Long QT
KW - Mapping
KW - Ventricular arrhythmias
UR - http://www.scopus.com/inward/record.url?scp=84886682468&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84886682468&partnerID=8YFLogxK
U2 - 10.1002/9781118481585.ch59
DO - 10.1002/9781118481585.ch59
M3 - Chapter
AN - SCOPUS:84886682468
SN - 9780470670460
SP - 644
EP - 655
BT - Cardiac Mapping: Fourth Edition
PB - Wiley-Blackwell
ER -